Voyager Therapeutics
VYGR
VYGR
70 hedge funds and large institutions have $145M invested in Voyager Therapeutics in 2022 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 17 increasing their positions, 18 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.3% less ownership
Funds ownership: 62.45% → 62.15% (-0.3%)
6% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 18
Holders
70
Holding in Top 10
1
Calls
$834K
Puts
$33K
Top Buyers
| 1 | +$1.54M | |
| 2 | +$670K | |
| 3 | +$666K | |
| 4 |
Citigroup
New York
|
+$493K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$435K |
Top Sellers
| 1 | -$1.71M | |
| 2 | -$1.12M | |
| 3 | -$752K | |
| 4 |
Morgan Stanley
New York
|
-$489K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$369K |